PT79182B - Mittel zur transdermalen applikation von arzneimittelwirkstoffen - Google Patents

Mittel zur transdermalen applikation von arzneimittelwirkstoffen

Info

Publication number
PT79182B
PT79182B PT79182A PT7918284A PT79182B PT 79182 B PT79182 B PT 79182B PT 79182 A PT79182 A PT 79182A PT 7918284 A PT7918284 A PT 7918284A PT 79182 B PT79182 B PT 79182B
Authority
PT
Portugal
Prior art keywords
medicamental
substances
medium
transdermal application
active medicinal
Prior art date
Application number
PT79182A
Other languages
German (de)
English (en)
Other versions
PT79182A (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT79182A publication Critical patent/PT79182A/pt
Publication of PT79182B publication Critical patent/PT79182B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/07—Microporous membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
PT79182A 1983-09-12 1984-09-07 Mittel zur transdermalen applikation von arzneimittelwirkstoffen PT79182B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333240 DE3333240A1 (de) 1983-09-12 1983-09-12 Mittel zur transdermalen applikation von arzneimittelwirkstoffen

Publications (2)

Publication Number Publication Date
PT79182A PT79182A (de) 1984-10-01
PT79182B true PT79182B (de) 1986-08-14

Family

ID=6209098

Family Applications (1)

Application Number Title Priority Date Filing Date
PT79182A PT79182B (de) 1983-09-12 1984-09-07 Mittel zur transdermalen applikation von arzneimittelwirkstoffen

Country Status (16)

Country Link
US (1) US5071657A (pt)
EP (1) EP0137278B1 (pt)
AT (1) ATE49126T1 (pt)
AU (1) AU3284984A (pt)
CA (1) CA1242143A (pt)
DE (2) DE3333240A1 (pt)
DK (1) DK164482C (pt)
ES (1) ES535860A0 (pt)
FI (1) FI83390C (pt)
GB (1) GB2146526B (pt)
GR (1) GR80327B (pt)
IL (1) IL72897A0 (pt)
NO (1) NO843594L (pt)
PH (1) PH21735A (pt)
PT (1) PT79182B (pt)
ZA (1) ZA847190B (pt)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8512016A8 (sl) * 1984-12-22 1996-10-31 Sanol Arznei Schwarz Gmbh Postopek za proizvodnjo obliža z aktivno substanco
ATE95430T1 (de) * 1984-12-22 1993-10-15 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
DE3600947A1 (de) * 1986-01-15 1987-07-16 Kali Chemie Pharma Gmbh Antimykotische emulsionen
US5560922A (en) * 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
FI872552A (fi) * 1986-06-09 1987-12-10 American Cyanamid Co Prostaglandinkomposition foer lokalt bruk.
FI872553A (fi) * 1986-06-09 1987-12-10 American Cyanamid Co Medium foer laekemedel foer lokalt bruk.
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
US4898920A (en) * 1987-10-15 1990-02-06 Dow Corning Corporation Adhesive compositions, controlled release compositions and transdermal delivery device
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
DE58909570D1 (de) 1988-10-27 1996-02-22 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
WO1990006120A1 (en) * 1988-12-01 1990-06-14 Schering Corporation Compositions for transdermal delivery of estradiol
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5229129A (en) * 1989-07-12 1993-07-20 Cygnus Therapeutic Systems Transdermal administration of lisuride
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride
FR2650747B1 (fr) * 1989-08-11 1994-02-11 Oreal Film composite pour traitement cutane local et procedes de fabrication correspondants
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
DE4033524A1 (de) * 1990-10-22 1992-04-23 Sanol Arznei Schwarz Gmbh Pharmazeutische verwendung von 1-(tert-butylamino)-3-((6-chloro-m-tolyl)oxy)-2-propanol in einer transdermalen applikationsform
ATE152747T1 (de) * 1990-11-06 1997-05-15 Sagami Chem Res An einem kettenende mit einem quaternären salz abgeschlossenes polyorganosiloxan und mittel zur förderung der perkutanen absorption
DE4116912A1 (de) * 1991-05-18 1992-11-26 Schering Ag Mittel zur transdermalen applikation enthaltend ergolin-derivate
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
JP3655305B2 (ja) * 1992-11-23 2005-06-02 エスティー ローダー インコーポレーテッド 自己日焼け化粧料組成物及びそれを使用する方法
DE69433994T2 (de) * 1993-01-19 2005-09-22 Endorecherche Inc., Ste-Foy Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
US6086921A (en) 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
US6063398A (en) * 1995-09-20 2000-05-16 L'oreal Cosmetic or dermopharmaceutical patch containing, in an anhydrous polymeric matrix, at least one active compound which is, in particular, unstable in oxidizing mediums, and at least one water-absorbing agent
FR2738744B1 (fr) * 1995-09-20 1997-10-24 Oreal Patch cosmetique ou dermo-pharmaceutique contenant dans une matrice polymerique au moins un compose actif en particulier instable en milieu oxydant et au moins un agent hydro-absorbant
JP3406773B2 (ja) * 1996-03-26 2003-05-12 東レ・ダウコーニング・シリコーン株式会社 フッ素樹脂被覆定着ロール用シリコーンゴム組成物およびフッ素樹脂被覆定着ロール
JP3628809B2 (ja) * 1996-06-10 2005-03-16 アルケア株式会社 薬剤徐放性医療用配合物及びその製造方法
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
TR200102867T2 (pt) * 1998-06-11 2002-06-21 Endorecherchel@Inc
US6800329B2 (en) * 1999-02-12 2004-10-05 Lts Lohmann Therapie-Systeme Ag Method for producing film-type dosage
DE19905801B4 (de) * 1999-02-12 2008-03-13 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung folienförmiger Darreichungsformen
DE19958554C2 (de) * 1999-07-02 2002-06-13 Lohmann Therapie Syst Lts Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung
ATE234081T1 (de) 1999-07-02 2003-03-15 Lohmann Therapie Syst Lts Mikroreservoirsystem auf basis von polysiloxanen und ambiphilen lösemitteln
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6562370B2 (en) 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6586000B2 (en) 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6582724B2 (en) 1999-12-16 2003-06-24 Dermatrends, Inc. Dual enhancer composition for topical and transdermal drug delivery
US6562369B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
US6562368B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
US6565879B1 (en) 1999-12-16 2003-05-20 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
AR030312A1 (es) 2000-08-03 2003-08-20 Antares Pharma Ipl Ag Composicion novedosa para la administracion transdermica y/o transmucosica de compuestos activos, que asegura adecuados niveles terapeuticos
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE60309667D1 (de) * 2002-02-15 2006-12-28 Endorech Inc Biphenylderivate und ihre verwendung als antiandrogene
US7328706B2 (en) 2002-05-06 2008-02-12 Dynamic Mouth Devices Llc Therapeutic and protective dental device useful as an intra-oral delivery system
PT1613297E (pt) * 2003-04-14 2007-08-23 Lohmann Therapie Syst Lts Emplastro terapêutico com matriz de polissiloxano compreendendo capsaicina
ES2377932T3 (es) 2003-10-10 2012-04-03 Ferring Bv Formulación farmacéutica transdérmica para minimizar los residuos sobre la piel
TWI383993B (zh) 2004-01-07 2013-02-01 Endorech Inc 螺旋１２取向性醫藥品
US20050181057A1 (en) * 2004-02-13 2005-08-18 Rosenberg Paul K. Vaginal lubricant
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US20060217691A1 (en) * 2005-02-25 2006-09-28 Georg Schuele Real-time therapeutic dosimetry based on dynamic response of treated tissue
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
US8067399B2 (en) 2005-05-27 2011-11-29 Antares Pharma Ipl Ag Method and apparatus for transdermal or transmucosal application of testosterone
US7709516B2 (en) 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
US20070048347A1 (en) * 2005-08-26 2007-03-01 Laura Bardach Intra-oral device for treating obesity
PL2450041T3 (pl) 2005-10-12 2019-02-28 Unimed Pharmaceuticals, Llc Ulepszony żel zawierający testosteron do zastosowania do leczenia hipogonadyzmu
US9284345B2 (en) 2007-04-12 2016-03-15 Endorecherche, Inc. 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
BRPI0914024A2 (pt) * 2008-10-10 2015-11-03 Teva Womens Health Inc formas de dosagem farmacêutica, embalagens e uso de acetato de ciproterona
ES2921527T3 (es) 2009-06-03 2022-08-29 Forsight Vision5 Inc Administración de fármaco en segmento anterior
US20100317635A1 (en) * 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
US8939948B2 (en) 2010-06-01 2015-01-27 Forsight Vision5, Inc. Ocular insert apparatus and methods
KR20130031339A (ko) 2010-06-16 2013-03-28 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법
CN104884006B (zh) 2012-10-26 2017-12-15 弗赛特影像5股份有限公司 用于持续释放药物到眼睛的眼科系统
WO2014110491A1 (en) 2013-01-11 2014-07-17 Theratrophix Llc Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
US10575976B2 (en) 2015-04-30 2020-03-03 Dynamic Mouth Devices, L.L.C. Method and apparatus for weight management utilizing an intra-oral device
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
AU7776275A (en) * 1974-04-11 1976-08-05 Warner Lambert Co Production of base for topical steroids
US4336243A (en) * 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad

Also Published As

Publication number Publication date
DK433584A (da) 1985-03-13
US5071657A (en) 1991-12-10
EP0137278A2 (de) 1985-04-17
ZA847190B (en) 1985-04-24
FI843580A0 (fi) 1984-09-12
GB2146526B (en) 1987-12-09
GB2146526A (en) 1985-04-24
ES8505248A1 (es) 1985-06-01
PH21735A (en) 1988-02-10
FI843580L (fi) 1985-03-13
ATE49126T1 (de) 1990-01-15
EP0137278A3 (en) 1986-12-30
FI83390C (fi) 1991-07-10
DK164482C (da) 1992-11-16
NO843594L (no) 1985-03-13
EP0137278B1 (de) 1990-01-03
CA1242143A (en) 1988-09-20
PT79182A (de) 1984-10-01
DK164482B (da) 1992-07-06
FI83390B (fi) 1991-03-28
AU3284984A (en) 1985-03-21
GR80327B (en) 1985-01-02
DE3480905D1 (de) 1990-02-08
GB8422973D0 (en) 1984-10-17
DE3333240A1 (de) 1985-03-28
DK433584D0 (da) 1984-09-11
IL72897A0 (en) 1984-12-31
ES535860A0 (es) 1985-06-01

Similar Documents

Publication Publication Date Title
PT79182B (de) Mittel zur transdermalen applikation von arzneimittelwirkstoffen
ES2051270T3 (es) Dispositivo de administracion transdermica de medicamentos.
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
ES2035259T3 (es) Compuesto absorbente.
IT8423534A0 (it) Dispositivo per ricevere e trattare sangue.
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
PT879056E (pt) Modulacao da expressao das citocinas th1/th2 atraves de ribavirina em linfocitos t activados
DK261490D0 (da) New pharmaceutical compound
DE3786714D1 (de) Therapeutisches mittel fuer hautgeschwuere.
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
DE69625918D1 (de) Lang wirksames mittel zur rektalen verabreichung
DE68920299D1 (de) Dichtung und diese verwendendes medizinisches Gerät.
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
ATE75610T1 (de) Pharmazeutische zubereitung zur behandlung des bluthochdrucks.
SE9101341D0 (sv) New medicinal use
ATE36333T1 (de) Hydantoin enthaltende therapeutische mittel.
ES549883A0 (es) Aparato electronico para la terapia medica y cosmetica.
ES1004391Y (es) Aparato electronico para la terapia medica y cosmetica.
NO991047D0 (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol
DE3676806D1 (de) Pharmazeutische zusammensetzung und behandlung.
FR2599974B1 (fr) Utilisation de la phospholipase a2, association et composition therapeutiques en resultant
TH6324EX (th) อุปกรณ์สำหรับใช้ในการรักษาโรคเหงือก

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990228